延迟COPD疾病进展,并提前升级至三重治疗:一个建模研究 (DEPICT-2)
Dave Singh1, Diego Fabian Litewka2, Joan B Soriano3
1Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
ERJ open research
|April 8, 2025
概括
双重支气管扩展剂和COPD的三重疗法显著保护肺功能,改善生活质量,降低死亡率. 这些治疗的早期启动和升级为COPD患者提供了长期的好处.
科学领域:
- 肺病学和呼吸系统医学
- 药物治疗和临床试验
- 卫生经济学和研究成果研究成果
背景情况:
- 双重支气管扩展剂 (LAMA/LABA) 和三重疗法 (ICS/LAMA/LABA) 已被确立用于短期至中期的COPD恶化和减少肺功能下降.
- 这些治疗策略对COPD患者的疾病进展,生活质量和存活率的长期影响仍然在很大程度上是未知的.
- 了解长期影响对于优化COPD管理和患者的治疗结果至关重要.
研究的目的:
- 模拟和探索双支支气管扩展剂和三重治疗对COPD患者肺功能下降的长期影响.
- 评估这些疗法对生活质量 (QoL) 的长期影响,使用圣乔治呼吸问卷 (SGRQ).
- 评估这些治疗策略对长期全因死亡率的影响.
主要方法:
- 采用了纵向非参数叠加模型,利用已发表的有关恶化,SGRQ得分和死亡率的数据.
- 从40岁到75岁模拟了疾病的进展.
- 该模型比较了在45岁开始LAMA/LABA治疗与在50岁升级到三重治疗,以及没有药物治疗.
主要成果:
- 到75岁时,与没有治疗相比,LAMA/LABA疗法保留了159.1毫升FEV1;升级到三重疗法保留了额外的376.5毫升FEV1.
- 仅用LAMA/LABA治疗的SGRQ得分提高了-3.2,并进一步提高到三重治疗的-7.5,表明提高了QoL.
- 与没有治疗相比,仅用LAMA/LABA治疗的死亡率降低了5.4%,并在75岁时使用三重疗法减少了12.0%,与没有治疗相比.
结论:
- 早期开始药物治疗,特别是双重支气管扩展剂治疗,可以减缓COPD疾病的进展.
- 从双重支气管扩展剂升级到三重疗法进一步增强了肺功能保护和QoL.
- 这些发现表明,及时和升级的药物治疗可以改善COPD患者的生存结果.
相关概念视频
COPD: Pathogenesis and Clinical Features
200
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
200
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


